Molecular Applications Group

Playing a visionary role in tissue characterization Minneapolis is a mecca for medical device companies; Cambridge and the Bay Area are cradles of biotechnology; and Pittsburgh is making a name for it

A year ago, Nobel Laureate Philip Sharp of the Massachusetts Institute of Technology cautioned against overstating the power of technology to address biological questions. "You've first got to unde

Selling research software is a tough way to generate big returns: the market is small and technology changes fast. To find profits, players are either going very deep into a few clients—or using the I

Dismal conditions in the public capital markets can't help but affect biotech start-ups too. Venture capitalists are reassessing operating and exit strategies, and contemplating new business models. b